FDA Drug Application (202806) for TAFINLAR by NOVARTIS PHARMS CORP

Back to FDA Applications sponsored by NOVARTIS PHARMS CORP

Application Number202806
Product Number001
FormCAPSULE;ORAL
DosageEQ 50MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTAFINLAR
Active IngredientDABRAFENIB MESYLATE



Back to FDA Applications sponsored by NOVARTIS PHARMS CORP